Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

ClinicalTrials.gov ID: NCT00337571

Public ClinicalTrials.gov record NCT00337571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 5:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Three Fixed Doses of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will compare the effectiveness (how well the drug works) of aripiprazole with placebo (fixed dose) in reducing serious behavioral problems in children and adolescents with a diagnosis of autistic disorder (AD).

Study identification

NCT ID
NCT00337571
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
218 participants

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2006 (Actual)
Primary completion
Jun 1, 2008 (Actual)
Completion
Jun 1, 2008 (Actual)
Last update posted
May 13, 2026

2006 – 2008

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
31
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35294 —
Harmonex Neuroscience Dothan Alabama 36303 —
Southwest Autism Research And Resource Center Phoenix Arizona 85006 —
Clinical Innovations, Inc. Huntington Beach California 92647 —
University Of California-Davis Medical Center Sacramento California 95817 —
Stanford University School Of Medicine Stanford California 94305 —
The Children'S Hospital Aurora Colorado 80045 —
Marsella, Gregory Boca Raton Florida 33432 —
University Of Florida Gainesville Florida 32611 —
University Of South Florida Tampa Florida 33613 —
Institute For Behavioral Medicine Smyrna Georgia 30080 —
University Of Illinois At Chicago Chicago Illinois 60606 —
Cambridge Health Alliance Medford Massachusetts 02139 —
Ladders Clinic Wellesley Massachusetts 02481 —
Children'S Hospital Of Michigan Detroit Michigan 48201 —
Regions Hospital Saint Paul Minnesota 55101 —
Children'S Mercy Hospital Kansas City Missouri 64108 —
Munroe-Meyer Institute Omaha Nebraska 68198 —
North Shore - Long Island Jewish Health System Bethpage New York 11714 —
Seaver And New York Autism Center Of Excellence New York New York 10029 —
Richmond Behavioral Associates Staten Island New York 10312 —
Mission Hospitals Asheville North Carolina 28801 —
Duke Child And Family Study Center Durham North Carolina 27710 —
The Nisonger Center Columbus Ohio 43210 —
Cutting Edge Research Oklahoma City Oklahoma 73116 —
Western Psychiatric Institute And Clinic Pittsburgh Pennsylvania 15203 —
Dallas Pediatric Neurology Associates Dallas Texas 75230 —
Bayou City Research, Ltd. Houston Texas 77007 —
Children'S National Medical Center Fairfax Virginia 22031 —
Pacific Institute Of Medical Sciences Bothell Washington 98011 —
Children'S Hospital Of Wisconsin Milwaukee Wisconsin 53201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00337571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00337571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →